The real benefits of semaglutide tablets for weight loss

The biggest misconception: tablets are the weaker option

Many people assume that because the tablet is newer and doesn't involve an injection, it must be less effective or somehow a compromise. That's not what the evidence says. A question our prescribers hear most weeks is whether the tablet "really works as well", and the honest answer is that it works meaningfully, with results that surprised even some clinicians when the OASIS 4 trial data came in.

In that phase 3 trial (307 adults with obesity or overweight alongside at least one weight-related condition, no diabetes, followed for 64 weeks) participants on oral semaglutide lost an average of around 13.6% of their body weight, compared with roughly 2.4% on placebo. Both groups made the same lifestyle changes, so the difference reflects the medicine. Among those who took every dose as directed, average loss reached approximately 17%. That's a meaningful result from a tablet taken before breakfast.

The context matters though. The weekly injection at its highest dose produced around 15% average loss in its pivotal trial (STEP 1, published in the New England Journal of Medicine). The oral route doesn't quite match that at the standard maintenance dose, but it closes the gap considerably, and for someone who genuinely cannot or will not use an injection, a 13–17% average is not a lesser treatment. It's a different one.

The MHRA licensed Wegovy tablets on 11 June 2026. The UK was the first country in Europe to take that step. You can read the NHS semaglutide guidance for a plain-language overview of how semaglutide works and what to expect.

The practical benefits people don't always consider first

No injection is the headline, but it's not the only practical advantage of the tablet form. Storage is one of the less-discussed ones. Injectable semaglutide requires refrigeration at 2–8°C; you keep it in the fridge and need to plan travel carefully. The tablet stores at room temperature. It can sit in a bag, a bathroom cabinet, a desk drawer. That sounds minor until you've tried to negotiate airport security with a cool bag.

The dosing routine is also straightforward once established. One tablet, first thing in the morning, with a small amount of plain water, up to around 120 ml. Then a wait of at least 30 minutes before any food, other drinks (including coffee) or other oral medicines. The wait is important: absorption depends on an empty stomach, and rushing it reduces how much semaglutide your body takes in. That discipline is the main thing the routine asks of you.

The escalation schedule starts at 1.5 mg and steps up through 4 mg and 9 mg to a 25 mg maintenance dose, with a minimum of a month at each level, the same gradual approach used with the injection, designed to let the body adjust and keep side effects manageable. If you want to understand how semaglutide oral tablets work across the full programme, that page covers it in detail, including what each dose stage involves. If you want to understand how the full tablet programme is structured, the Wegovy pill overview covers it in detail.

For people already established on the 2.4 mg weekly injection, a move to the 25 mg tablet is possible, but that's a clinical decision, made with your prescriber, not something to arrange independently. The absorption mechanism is different enough that it isn't a straight swap.

Who the tablet suits, and where the limits are

The MHRA licensed Wegovy tablets for adults with a BMI of 30 or above, or 27–29.9 with at least one weight-related condition such as high blood pressure, high cholesterol or obstructive sleep apnoea. Those are the same broad parameters as the injectable form, though the full eligibility picture always depends on a clinical review of your individual health history.

The tablet is particularly worth considering if needles are a genuine barrier to starting treatment, not just a mild preference. Needle anxiety is common and legitimate; it keeps some people from ever asking about injectable GLP-1 medicines. The oral route removes that barrier entirely.

It may also suit people whose daily schedule makes a once-daily tablet easier to remember than a weekly injection with storage and preparation steps. Some people find the ritual of a morning tablet simpler to maintain. There's no clinical superiority in the routine itself, it just fits some lives better.

The side-effect profile overlaps significantly with the injection: nausea, diarrhoea, constipation and indigestion are the most common, and they're most noticeable during dose increases. In the OASIS 4 trial, 74% of participants on oral semaglutide reported gastrointestinal effects, mostly mild to moderate and settling over time. If you want to understand what the semaglutide tablet experience looks like in practice, including how side effects typically progress through the dose stages, that page goes through it in more depth, drawing on the same NHS guidance. If you want to understand what that looks like in practice, the semaglutide tablets page goes through it in more depth, drawing on the same NHS guidance.

What this is not: it isn't available on the NHS yet. A NICE appraisal would be needed before that changes. For now, Wegovy tablets are available through private prescription only, and what that costs varies by provider and dose stage. Whatever the price, it should always include a legitimate clinical assessment, not just a form you fill in and ignore.

The one thing the tablet cannot do that the injection can

Wegovy tablets have been approved for weight management only, adults with a BMI of 30 or above (or 27-plus with a qualifying condition). The injectable form also holds a UK authorisation for reducing cardiovascular event risk in certain eligible adults, and as of July 2026 it carries a conditional approval for a form of liver disease called MASH. The tablet does not currently share those indications.

That distinction matters if cardiovascular risk reduction is part of why a prescriber has suggested semaglutide, the tablet alone wouldn't cover that licensed use. For most people starting treatment primarily for weight management, the distinction doesn't affect their day-to-day treatment, but it's worth knowing. If you're specifically looking at the starting point of the dose escalation, our page on semaglutide 7mg tablets explains what that early stage involves and what to expect from it.

If you'd like to explore whether oral semaglutide is appropriate for you, our prescribers at nume (sorry, at nume) review every consultation personally, the same day. Check your eligibility through our free consultation and get a clinical answer rather than a best guess.